891 related articles for article (PubMed ID: 26921847)
1. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment.
de Groof EJ; Sahami S; Lucas C; Ponsioen CY; Bemelman WA; Buskens CJ
Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847
[TBL] [Abstract][Full Text] [Related]
2. The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease.
Haennig A; Staumont G; Lepage B; Faure P; Alric L; Buscail L; Bournet B; Moreau J
Colorectal Dis; 2015 Apr; 17(4):311-9. PubMed ID: 25425534
[TBL] [Abstract][Full Text] [Related]
3. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
[TBL] [Abstract][Full Text] [Related]
4. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Perianal Fistulas in Crohn's Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial.
Wasmann KA; de Groof EJ; Stellingwerf ME; D'Haens GR; Ponsioen CY; Gecse KB; Dijkgraaf MGW; Gerhards MF; Jansen JM; Pronk A; van Tuyl SAC; Zimmerman DDE; Bruin KF; Spinelli A; Danese S; van der Bilt JDW; Mundt MW; Bemelman WA; Buskens CJ
J Crohns Colitis; 2020 Sep; 14(8):1049-1056. PubMed ID: 31919501
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
Bor R; Farkas K; Bálint A; Szűcs M; Abrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Orv Hetil; 2013 Dec; 154(49):1943-8. PubMed ID: 24292112
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
8. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
Schwartz DA; White CM; Wise PE; Herline AJ
Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987
[TBL] [Abstract][Full Text] [Related]
9. Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
Bouchard D; Abramowitz L; Bouguen G; Brochard C; Dabadie A; de Parades V; Eléouet-Kaplan M; Fathallah N; Faucheron JL; Maggiori L; Panis Y; Pigot F; Rouméguère P; Sénéjoux A; Siproudhis L; Staumont G; Suduca JM; Vinson-Bonnet B; Zeitoun JD
Tech Coloproctol; 2017 Sep; 21(9):683-691. PubMed ID: 28929282
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713
[TBL] [Abstract][Full Text] [Related]
11. Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
Strik AS; Löwenberg M; Buskens CJ; B Gecse K; I Ponsioen C; Bemelman WA; D'Haens GR
Scand J Gastroenterol; 2019 Apr; 54(4):453-458. PubMed ID: 31032686
[No Abstract] [Full Text] [Related]
12. Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial.
de Groof EJ; Buskens CJ; Ponsioen CY; Dijkgraaf MG; D'Haens GR; Srivastava N; van Acker GJ; Jansen JM; Gerhards MF; Dijkstra G; Lange JF; Witteman BJ; Kruyt PM; Pronk A; van Tuyl SA; Bodelier A; Crolla RM; West RL; Vrijland WW; Consten EC; Brink MA; Tuynman JB; de Boer NK; Breukink SO; Pierik MJ; Oldenburg B; van der Meulen AE; Bonsing BA; Spinelli A; Danese S; Sacchi M; Warusavitarne J; Hart A; Yassin NA; Kennelly RP; Cullen GJ; Winter DC; Hawthorne AB; Torkington J; Bemelman WA
Trials; 2015 Aug; 16():366. PubMed ID: 26289163
[TBL] [Abstract][Full Text] [Related]
13. The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort study.
Sebastian S; Black C; Pugliese D; Armuzzi A; Sahnan K; Elkady SM; Katsanos KH; Christodoulou DK; Selinger C; Maconi G; Fearnhead NS; Kopylov U; Davidov Y; Bosca-Watts MM; Ellul P; Muscat M; Karmiris K; Hart AL; Danese S; Ben-Horin S; Fiorino G
Aliment Pharmacol Ther; 2018 Nov; 48(9):941-950. PubMed ID: 30226271
[TBL] [Abstract][Full Text] [Related]
14. Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn's disease: a Brazilian multicenter observational study.
Kotze PG; Albuquerque IC; da Luz Moreira A; Tonini WB; Olandoski M; Coy CS
Arq Gastroenterol; 2014; 51(4):284-9. PubMed ID: 25591155
[TBL] [Abstract][Full Text] [Related]
15. Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.
Plevris N; Jenkinson PW; Arnott ID; Jones GR; Lees CW
Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):32-37. PubMed ID: 31567638
[TBL] [Abstract][Full Text] [Related]
16. Review of local injection of anti-TNF for perianal fistulising Crohn's disease.
Adegbola SO; Sahnan K; Tozer PJ; Phillips RK; Faiz OD; Warusavitarne J; Hart A
Int J Colorectal Dis; 2017 Nov; 32(11):1539-1544. PubMed ID: 28900730
[TBL] [Abstract][Full Text] [Related]
17. Managing perianal Crohn's fistula in the anti-TNFα era.
Tozer P; Borowski DW; Gupta A; Yassin N; Phillips R; Hart A
Tech Coloproctol; 2015 Nov; 19(11):673-8. PubMed ID: 26264168
[TBL] [Abstract][Full Text] [Related]
18. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement.
Regueiro M; Mardini H
Inflamm Bowel Dis; 2003 Mar; 9(2):98-103. PubMed ID: 12769443
[TBL] [Abstract][Full Text] [Related]
19. A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas.
Spradlin NM; Wise PE; Herline AJ; Muldoon RL; Rosen M; Schwartz DA
Am J Gastroenterol; 2008 Oct; 103(10):2527-35. PubMed ID: 18684178
[TBL] [Abstract][Full Text] [Related]
20. Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease.
Gu B; Venkatesh K; Williams AJ; Ng W; Corte C; Gholamrezaei A; Ghaly S; Xuan W; Paramsothy S; Connor S
World J Gastroenterol; 2022 Jun; 28(23):2597-2608. PubMed ID: 35949350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]